Retrospective Study
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Virol. Dec 25, 2024; 13(4): 96573
Published online Dec 25, 2024. doi: 10.5501/wjv.v13.i4.96573
COVID-19 in pregnancy: Perinatal outcomes and complications
Karolina Akinosoglou, Georgios Schinas, Evangelia Papageorgiou, Theodoros Karampitsakos, Vasiliki Dimakopoulou, Eleni Polyzou, Argyrios Tzouvelekis, Markos Marangos, Despoina Papageorgiou, Nikolaos Spernovasilis, George Adonakis
Karolina Akinosoglou, Georgios Schinas, Vasiliki Dimakopoulou, Eleni Polyzou, Markos Marangos, Despoina Papageorgiou, Department of Medicine, University of Patras, Patras 26504, Greece
Evangelia Papageorgiou, George Adonakis, Department of Obstetrics and Gynecology, University General Hospital of Patras, Patras 26504, Greece
Theodoros Karampitsakos, Argyrios Tzouvelekis, Department of Pneumonology, University General Hospital of Patras, Patras 26504, Greece
Nikolaos Spernovasilis, Department of Infectious Diseases, German Oncology Center, Limassol 4108, Limassol, Cyprus
Author contributions: Akinosoglou K and Adonakis G conceived idea; Schinas G, Papageorgiou E, Karampitsakos T, Dimakopoulou V, and Polyzou E collected data; Schinas G analyzed data; Akinosoglou K and Papageorgiou D wrote manuscript; Akinosoglou K, Tzouvelekis A, Marangos M, and Adonakis G oversaw study; Spernovasilis N critically corrected manuscript; Schinas G and Papageorgiou E equally contributed to this work.
Institutional review board statement: The study was approved by the institute ethics committee of the University Hospital of Patras (Approval No.: 477/24.11.2022).
Informed consent statement: Due to the retrospective type of the study a signed by the participants informed consent form was not necessary.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Nikolaos Spernovasilis, MD, MSc, PhD, Director, Department of Infectious Diseases, German Oncology Center, Nikis 1, Limassol 4108, Limassol, Cyprus. nikspe@hotmaiil.com
Received: May 9, 2024
Revised: August 28, 2024
Accepted: September 6, 2024
Published online: December 25, 2024
Processing time: 161 Days and 14.8 Hours
Core Tip

Core Tip: Pregnant individuals' risk of contracting severe disease from severe acute respiratory syndrome coronavirus 2 infection is elevated. If hospitalization for coronavirus disease 2019 is indicated for expecting mothers, it is crucial the medical treatment to take place in a facility equipped to monitor both maternal and fetal health. Early detection and management of these cases are paramount for optimal results regarding motherhood and newborn care outcomes.